Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.42 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL954191 | 0.82 | GABRA1 (0.48) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL1527132 | 0.77 | GABRA1 (0.54) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL3426311 | 0.76 | MEN1 (0.44) | LMNACA1CA2TSHRBLM | |
| SCHEMBL21270 | 0.75 | GABRA1 (0.54) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL29430856 | 0.75 | GABRA1 (0.54) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL6216932 | 0.75 | TSHR (0.41) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL6208275 | 0.75 | ALDH1A1 (0.45) | CA1CA2TSHRKMT2AMEN1 | |
| SCHEMBL29952004 | 0.75 | TSHR (0.41) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL320584 | 0.73 | ALDH1A1 (0.61) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL1984475 | 0.73 | ALDH1A1 (0.61) | LMNACYP1A2TSHRSLC6A2HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12137604-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-11-05 | — | — | US | disclosed |
| CN-113004337-B | Organometallic compound and organic light emitting device including the same | 三星电子株式会社 | 2024-09-20 | — | — | CN | disclosed |
| US-20210193937-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-24 | — | — | US | disclosed |
| EP-3838908-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | Samsung Electronics Co., Ltd. (KR) | 2021-06-23 | — | — | EP | disclosed |
| CN-113004337-A | Organometallic compound and organic light emitting device including the same | 三星电子株式会社 | 2021-06-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12137604-B2 | Organometallic compound and organic light-emitting device including the same | CYC1, CYBA, CRY2 | GABRA1 2941/4885GABRG2 3243/4885GABRB3 4208/4885 |
| US-20210193937-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CYC1, CYBA, CRY2 | GABRA1 2941/4885GABRG2 3243/4885GABRB3 4208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.